Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
fda
2 min read • May 31, 2019
Regarding Today’s FDA Hearing On Cannabis-Derived Compounds
3 min read • May 30, 2019
FDA To Hold CBD Hearing Friday: What You Should Know
2 min read • May 30, 2019
Zynerba Pharma Highlights Will Present At FDA’s Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-derived Compounds
3 min read • May 30, 2019
Stakeholders Await The FDA’s First Public Hearing About Cannabis And CBD
4 min read • April 18, 2019
A Gap In Standards Leads To Industry Uncertainty About Synthetic CBD
21 min read • April 14, 2019
The Week In Cannabis News: SAFE Banking Act In The Senate, Greenlane’s IPO, B-Real, Canopy Growth And More
21 min read • April 7, 2019
This Week’s Cannabis News: The FDA And CBD, The STATES Act, Cresco And Origin House, Europe And High Times
3 min read • March 6, 2019
Gottlieb’s Departure Creates Uncertainty For Tobacco, Biopharma, Cannabis Industries
2 min read • December 24, 2018
FDA: CBD Products Mostly Illegal
3 min read • December 21, 2018
FDA Warms To Considering Legal Cannabis Ingredients In Food
1 min read • December 20, 2018
FDA’s Gottlieb Says Will Advance New Steps To Better Define FDA’s Public Health Obligations In Area Of Cannabis
6 min read • December 20, 2018
The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Latest Headlines
View All
13 min read • September 1, 2026
Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal
6 min read • September 1, 2026
Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.
4 min read • August 31, 2026
Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2
5 min read • August 31, 2026
Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell
6 min read • August 31, 2026
USCR Urges Congress to Keep the Hemp Loophole Closed
4 min read • August 28, 2026
Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1
3 min read • August 28, 2026
$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says
2 min read • August 28, 2026
PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off
5 min read • August 27, 2026
Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns
2 min read • August 27, 2026
IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing
4 min read • August 26, 2026
Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask
3 min read • August 26, 2026
Financial Times: Germany’s Cannabis Imports Surge Sixfold, Regulatory Pressure Mounts
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis clubs
cannabis cultivation
cannabis earnings
cannabis farms
cannabis study
CBD
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
germany cannabis
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
hemp rules
Hot
IgniteIt Events
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
WNBA
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.